| mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |